Cisplatin and Oxaliplatin Toxicity: Importance of Cochlear Kinetics as a Determinant for Ototoxicity
作者： V. Hellberg , I. Wallin , S. Eriksson , E. Hernlund , E. Jerremalm
DOI: 10.1093/JNCI/DJN418
关键词:
摘要: BACKGROUND: Cisplatin is a cornerstone anticancer drug with pronounced ototoxicity, whereas oxaliplatin, platinum derivative different clinical profile, rarely ototoxic. This difference ...
oup.com
paperity.org
oxfordjournals.org参考文章(45)
Mahin D. Maines, Current protocols in toxicology John Wiley. ,(1999)
Maria Hägg, Kenneth Bivén, Takayuki Ueno, Lars Rydlander, Peter Björklund, Klas G. Wiman, Maria Shoshan, Stig Linder, A novel high-through-put assay for screening of pro-apoptotic drugs. Investigational New Drugs. ,vol. 20, pp. 253- 259 ,(2002) , 10.1023/A:1016249728664
Elias S.J. Arnér, Arne Holmgren, Measurement of Thioredoxin and Thioredoxin Reductase Current protocols in immunology. ,vol. 24, ,(2005) , 10.1002/0471140856.TX0704S05
Jonas Nordberg, Elias S.J. Arnér, Reactive oxygen species, antioxidants, and the mammalian thioredoxin system1 1This review is based on the licentiate thesis “Thioredoxin reductase—interactions with the redox active compounds 1-chloro-2,4-dinitrobenzene and lipoic acid” by Jonas Nordberg, 2001, Karolinska Institute, Stockholm, ISBN 91-631-1064-4. Free Radical Biology and Medicine. ,vol. 31, pp. 1287- 1312 ,(2001) , 10.1016/S0891-5849(01)00724-9
Pernilla Videhult, Göran Laurell, Inger Wallin, Hans Ehrsson, Kinetics of Cisplatin and its monohydrated complex with sulfur-containing compounds designed for local otoprotective administration. Experimental Biology and Medicine. ,vol. 231, pp. 1638- 1645 ,(2006) , 10.1177/153537020623101009
Jinhua Yuan, Estimation of variance for AUC in animal studies Journal of Pharmaceutical Sciences. ,vol. 82, pp. 761- 763 ,(1993) , 10.1002/JPS.2600820718
H. Ehrsson, I. Wallin, J. Yachnin, Pharmacokinetics of oxaliplatin in humans Medical Oncology. ,vol. 19, pp. 261- 265 ,(2002) , 10.1385/MO:19:4:261
S.-R. Lee, S. Bar-Noy, J. Kwon, R. L. Levine, T. C. Stadtman, S. G. Rhee, Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 2521- 2526 ,(2000) , 10.1073/PNAS.050579797
Xilin Ren, Mikael Bjoernstedt, Bojiang Shen, Mats L. Ericson, Arne Holmgren, Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione Biochemistry. ,vol. 32, pp. 9701- 9708 ,(1993) , 10.1021/BI00088A023
Sabine Urig, Katja Becker, On the potential of thioredoxin reductase inhibitors for cancer therapy. Seminars in Cancer Biology. ,vol. 16, pp. 452- 465 ,(2006) , 10.1016/J.SEMCANCER.2006.09.004